Robin McKinney, MD, explains what neurally adjusted ventilatory assist (NAVA) is, the research around its use in children and adults, and what this all means for clinical practice. For more, visit www.consultant360.com/pulmonology.

Eileen O’Grady, PhD, RN, NP, founder of the School of Wellness, discusses intentional change, positive psychology, and similar mental health initiatives in relation to the PERMA model. For more, visit www.consultant360.com.

Rashi Aggarwal, MD, from Rutgers New Jersey Medical School, discusses screening tools and treatment options for diagnosing and managing posttraumatic stress disorder in the primary care setting. For more, visit www.consultant360.com.

William D. Chey, MD, from Michigan Medicine, highlights the 3 phases of a low FODMAP diet in the treatment of IBS and the importance of moving a patient from the elimination phase to the reintroduction phase.

Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks. For more content, visit https://www.consultant360.com/infectious-diseases.

Children with autism are more likely to have epilepsy, and vice versa. Madeline Fields, MD, from Mount Sinai Hospital, answers our questions about this connection.

Valeria C. Cohran, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, discusses the current state of pediatric intestinal rehabilitation programs, treatment advances led by these programs, and more.

Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case #3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing. Case part 3 here:

In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient. Part 1 here: https://www.consultant360.com/exclusive/cardiology/lipid-metabolic/what-older-mans-ldl-c-goal.

Jacob Miguel Vigil, PhD, discusses new study findings that suggest THC may confer more therapeutic benefit than CBD across many different health conditions, and why he says now is the “Golden Age” of cannabis research. For more, visit www.consultant360.com.